SILO PHARMA, INC. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
SILO PHARMA, INC. (SILO) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $4.24 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2023-08-11
- SILO PHARMA, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2023-06-30 was $4.24K, a 71.96% decline year-over-year.
- SILO PHARMA, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2022-06-30 was $15.11K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month |
|---|---|
| 2023-06-30 | $4.24K 10-Q · filed 2023-08-11 |
| 2022-06-30 | $15.11K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |